MCP Danish Cancer Society
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/mcp.R500008-MCP200 on February 2, 2005.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
R500008-MCP200v1
4/4/545    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wright, M. E.
Right arrow Articles by Aebersold, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wright, M. E.
Right arrow Articles by Aebersold, R.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 4:545-554, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.

Review

Mass Spectrometry-based Expression Profiling of Clinical Prostate Cancer

Michael E. Wright{ddagger},§, David K. Han and Ruedi Aebersold§,||

From the {ddagger} UC Davis Genome Center, Department of Pharmacology and Toxicology, University of California Davis School of Medicine, Davis, CA 95616; Department of Cell Biology, University of Connecticut Health Center, Farmington, CT 06030; and || Institute for Systems Biology, Seattle, WA, Institute for Molecular Systems Biology, ETH-Zuerich, and Faculty of Natural Sciences, University of Zurich, ETH-Honggerberg, HPT E 78 Wolfgang Pauli-Str. 16, Zurich CH-8093, Switzerland

The maturation of MS technologies has provided a rich opportunity to interrogate protein expression patterns in normal and disease states by applying expression protein profiling methods. Major goals of this research strategy include the identification of protein biomarkers that demarcate normal and disease populations, and the identification of therapeutic biomarkers for the treatment of diseases such as cancer (Celis, J. E., and Gromov, P. (2003) Proteomics in translational cancer research: Toward an integrated approach. Cancer Cell 3, 9–151). Prostate cancer is one disease that would greatly benefit from implementing MS-based expression profiling methods because of the need to stratify the disease based on molecular markers. In this review, we will summarize the current MS-based methods to identify and validate biomarkers in human prostate cancer. Lastly, we propose a reverse proteomic approach implementing a quantitative MS research strategy to identify and quantify biomarkers implicated in prostate cancer development. With this approach, the absolute levels of prostate cancer biomarkers will be identified and quantified in normal and diseased samples by measuring the levels of native peptide biomarkers in relation to a chemically identical but isotopically labeled reference peptide. Ultimately, a centralized prostate cancer peptide biomarker expression database could function as a repository for the identification, quantification, and validation of protein biomarker(s) during prostate cancer progression in men.

§ To whom correspondence should be addressed: Michael E. Wright, UC Davis Genome Center, Department of Pharmacology and Toxicology, University of California Davis School of Medicine, Davis, CA. E-mail: mewright{at}ucdavis.edu. Ruedi Aebersold, Institute for Molecular Systems Biology, ETH-Zuerich, and Faculty of Natural Sciences, University of Zurich, Switzerland. E-mail: aebersold{at}biotech.biol.ethz.ch


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Mol. Cell. ProteomicsHome page
R. R. Drake, E. E. Schwegler, G. Malik, J. Diaz, T. Block, A. Mehta, and O. J. Semmes
Lectin Capture Strategies Combined with Mass Spectrometry for the Discovery of Serum Glycoprotein Biomarkers
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1957 - 1967.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
W.-J. Qian, J. M. Jacobs, T. Liu, D. G. Camp II, and R. D. Smith
Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1727 - 1744.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
S.-L. Wu, J. Kim, R. W. Bandle, L. Liotta, E. Petricoin, and B. L. Karger
Dynamic Profiling of the Post-translational Modifications and Interaction Partners of Epidermal Growth Factor Receptor Signaling after Stimulation by Epidermal Growth Factor Using Extended Range Proteomic Analysis (ERPA)
Mol. Cell. Proteomics, September 1, 2006; 5(9): 1610 - 1627.
[Abstract] [Full Text] [PDF]

Home page
 Brief Funct Genomic ProteomicHome page
B. Canas, D. Lopez-Ferrer, A. Ramos-Fernandez, E. Camafeita, and E. Calvo
Mass spectrometry technologies for proteomics
Brief Funct Genomic Proteomic, February 1, 2006; 4(4): 295 - 320.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.